SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Kimia Biosciences Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
530313 INE285U01025 0.0815159 Not Listed 0 239.07 0 0 1
Quarters :
ParticularsDec 2023(Rs.Cr)Sep 2023(Rs.Cr)Jun 2023(Rs.Cr)
Gross Sales26.1424.2024.23
Other Operating Income0.000.000.00
Other Income 0.580.640.13
Total Income26.7224.8424.36
Total Expenditure 27.1926.1625.87
PBIDT-0.47-1.32-1.51
Interest 1.311.121.28
PBDT-1.78-2.44-2.79
Depreciation0.820.820.83
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.65-0.82-0.91
Reported Profit After Tax-1.95-2.44-2.71
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-1.95-2.44-2.71
    
EPS (Unit Curr.)-0.41-0.52-0.57
EPS (Adj) (Unit Curr.)-0.41-0.52-0.57
Calculated EPS (Unit Curr.)-0.41-0.52-0.57
Calculated EPS (Adj) (Unit Curr.)-0.41-0.52-0.57
Calculated EPS (Ann.) (Unit Curr.)-1.65-2.06-2.29
Calculated EPS (Adj) (Ann.) (Unit Curr.)-1.65-2.06-2.29
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity4.734.734.73
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)-1.80-5.45-6.23
PBDTM(%)-6.81-10.08-11.51
PATM(%)-7.46-10.08-11.18